AbbVie Inventory

AbbVie (4AB.DE) currently reports a inventory of $5.1B as of June 2026. That compares with $5B in the prior-year period — up 3.4% year over year. Use the charts on this page to explore AbbVie's inventory history and peer comparisons.

AbbVie's inventory increased from $5B to $5.1B — a 3.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AbbVie reported $5.1B in inventory as of June 2026. That compares with $5B in the prior-year period — up 3.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $5.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AbbVie, and consider following 4AB.DE for alerts when major investors trade the stock.

AbbVie is classified in the Healthcare sector. On inventory, it currently shows $5.1B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4AB.DE with unrelated industries.